Luyan Jiao
Vice President - New Drug Development Nuwacell
Ph.D. and Postdoctoral , Sun Yat-sen University
Primarily responsible for project initiation and management within the company, with a solid background in medical science, as well as excellent capabilities in strategic planning, project management and risk control.
Seminars
Wednesday 9th September 2026
Advancing Hypoimmune iPSC‑Derived Dopaminergic Progenitors (NCR201) Toward Clinical Translation in Parkinson’s Disease
8:30 am
- Sharing early safety and tolerability insights from Nuwacell’s NCR201 Phase I/II trial
- Highlighting long-term efficacy and biological activity from investigator-initiated trials
- Building scalable CMC foundations aligned with NCR201’s accelerated development route
